HFCP X (Parallel-A), L.P. 4
Research Summary
AI-generated summary
Medline (MDLN) 10% Owner Exchanges 18.16M Units for Class A Shares
What Happened
Hellman & Friedman Capital Partners X (Parallel), L.P. (a reported 10% owner via related entities) effected a conversion/exchange on May 21, 2026 in which 18,156,867 common units of Medline Holdings, LP were exchanged for an equal number of Medline Inc. Class A common shares. The filing shows the conversion entries with N/A for price (no cash purchase or sale); the issuer automatically cancelled an equivalent number of Class B common shares held by the exchanging holder.
Key Details
- Transaction date: May 21, 2026; Form 4 filed May 26, 2026.
- Amount converted/exchanged: 18,156,867 units → 18,156,867 Class A shares. No per‑share price or cash value reported (N/A).
- Shares owned after transaction: not specified in the filing for the reporting entities (the filing disclaims beneficial ownership except to the extent of pecuniary interest).
- Notable footnotes:
- Holders have a perpetual right (one‑for‑one, adjusted for splits/dividends) to exchange common units for Class A shares (Footnote F1).
- Mend Investment Holdings I, L.P. performed the exchange and the equivalent Class B shares were automatically cancelled (F2, F5).
- Complex ownership/GP structure ties the converted units to Hellman & Friedman entities; a three‑member board (Investors X Ltd.) has voting/investment discretion and disclaims beneficial ownership (F3–F4).
- Timeliness: The trade occurred 5 days before filing; the Form includes a disclaimer that the reporting persons are filing under Rule 16a‑3(j) and disclaim being subject to Section 16, which may explain timing.
Context
- This was an institutional conversion of partnership units into publicly tradable Class A shares, not an executive open‑market buy or sale. It involved automatic cancellation of Class B shares (which carry one vote and no economic value) upon exchange.
- Such conversions are routine for holders of partnership common units who elect to take shares of the corporation; they do not necessarily signal a buy/sell decision by corporate insiders.